Literature DB >> 24067621

Role of hysteroscopy prior to assisted reproduction techniques.

Panagiotis Bakas1, Dimitrios Hassiakos2, Charalampos Grigoriadis2, Nikolaos Vlahos2, Angelos Liapis2, Odysseas Gregoriou2.   

Abstract

STUDY
OBJECTIVE: To determine whether diagnostic hysteroscopy before assisted reproduction techniques (ΑRT) in women without known disease of the uterine cavity is necessary.
DESIGN: Prospective cohort clinical study.
SETTING: Reproductive medicine clinic. PATIENTS: The study group consisted of 217 infertile women attending the Reproductive Clinic for examination before undergoing ART, either in vitro fertilization or intracytoplasmic sperm injection.
INTERVENTIONS: Patients underwent transvaginal sonography (TVS) and hysterosalpingography (HSG) for initial evaluation. If there were no abnormal intrauterine findings, diagnostic hysteroscopy was additionally performed.
MEASUREMENTS AND MAIN RESULTS: The safety and diagnostic value of hysteroscopy before ART was examined. Diagnostic hysteroscopy was performed successfully, without complications, in all 217 women. Ninety-five (43.7%) had a history of ART failures (group 1), and 122 (56.3%) had undergone no previous ART attempts (group 2). In 148 women (68.2%), findings at hysteroscopy were normal, whereas in 69 (31.8%), hysteroscopy revealed intrauterine lesions (polyps, septa, submucosal leiomyomas, or synechiae) that led to operative hysteroscopy. The most common intrauterine abnormality was the presence of endometrial polyps in 26 patients (12%). The total percentage of abnormal intrauterine findings was higher in women with a history of repeated ART failures in comparison with those with no history of ART attempts. No statistically significant difference in the outcome of in vitro fertilization or intracytoplasmic sperm injection was observed between women with normal hysteroscopic findings and patients with hysteroscopically corrected endometrial disease.
CONCLUSION: Sensitivity of diagnostic hysteroscopy is significantly higher than TVS and HSG in the diagnosis of intrauterine lesions. Diagnostic hysteroscopy should be performed before ART in all patients, including women with normal TVS and/or HSG findings, because a significant percentage of them have undiagnosed uterine disease that may impair the success of fertility treatment.
Copyright © 2014 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Assisted reproduction techniques; Hysterosalpingography; Hysteroscopy; Infertility; Intracytoplasmic sperm injection; In vitro fertilization

Mesh:

Year:  2013        PMID: 24067621     DOI: 10.1016/j.jmig.2013.07.023

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  5 in total

Review 1.  What is the role of hysteroscopic surgery in the management of female infertility? A review of the literature.

Authors:  Márcia Mendonça Carneiro
Journal:  Surg Res Pract       Date:  2014-03-03

2.  Live birth after hysteroscopy performed inadvertently during early pregnancy: A case report and review of literature.

Authors:  Chong-Yi Zhao; Feng Ye
Journal:  World J Clin Cases       Date:  2018-10-26       Impact factor: 1.337

3.  Uterine alterations in women undergoing routine hysteroscopy before in vitro fertilization: high prevalence of unsuspected lesions.

Authors:  Cecília S Monteiro; Ines K Cavallo; Júlia A Dias; Francisco A N Pereira; Fernando M Reis
Journal:  JBRA Assist Reprod       Date:  2019-10-14

Review 4.  Hysteroscopy as An Investigational Operative Procedure in Primary and Secondary Infertility: A Systematic Review.

Authors:  Fortunato Genovese; Federica Di Guardo; Morena Maria Monteleone; Valentina D'Urso; Francesco Maria Colaleo; Vito Leanza; Marco Palumbo
Journal:  Int J Fertil Steril       Date:  2021-03-11

5.  Hysteroscopic cervical features associated with difficult embryo transfer in unselected patients undergoing in vitro fertilization.

Authors:  Yu-Che Ou; Kuan-Hui Huang; Kuo-Chung Lan
Journal:  Biomed J       Date:  2021-07-05       Impact factor: 7.892

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.